Free Trial
NYSEAMERICAN:ASXC

Asensus Surgical (ASXC) Stock Price, News & Analysis

Asensus Surgical logo
$0.35
0.00 (0.00%)
(As of 08/22/2024)

About Asensus Surgical Stock (NYSEAMERICAN:ASXC)

Key Stats

Today's Range
$0.35
$0.35
50-Day Range
N/A
52-Week Range
$0.17
$0.40
Volume
N/A
Average Volume
2.03 million shs
Market Capitalization
$94.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.35
Consensus Rating
Hold

Company Overview

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Receive ASXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter.

ASXC Stock News Headlines

Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
See More Headlines

ASXC Stock Analysis - Frequently Asked Questions

Asensus Surgical's stock was trading at $0.2466 at the beginning of 2024. Since then, ASXC shares have increased by 41.1% and is now trading at $0.3479.
View the best growth stocks for 2024 here
.

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) released its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.02. The firm earned $2.21 million during the quarter, compared to analysts' expectations of $1.30 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%.

Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asensus Surgical investors own include Block (SQ), Digital Turbine (APPS), Palantir Technologies (PLTR), CrowdStrike (CRWD), ChargePoint (CHPT), SoFi Technologies (SOFI) and Tesla (TSLA).

Company Calendar

Last Earnings
8/13/2024
Today
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:ASXC
CIK
N/A
Employees
170
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.35
High Stock Price Target
$0.35
Low Stock Price Target
$0.35
Potential Upside/Downside
+0.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-78,430,000.00
Net Margins
-902.25%
Pretax Margin
-899.16%

Debt

Sales & Book Value

Annual Sales
$8.58 million
Book Value
$0.13 per share

Miscellaneous

Free Float
264,516,000
Market Cap
$94.74 million
Optionable
Not Optionable
Beta
1.37
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NYSEAMERICAN:ASXC) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners